- Home
- KORE vs IBIO Comparison
KORE vs IBIO Comparison
Compare KORE & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KORE | IBIO |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | United States | United States |
| Employees | 539 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.6M | 72.2M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | KORE | IBIO |
|---|---|---|
| Price | $9.18 | $1.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $5.00 | $4.75 |
| AVG Volume (30 Days) | 28.9K | ★ 887.3K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.96 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.00 | $0.56 |
| 52 Week High | $9.22 | $3.82 |
Technical Indicators
Market Signals| Indicator | KORE | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 71.36 | 38.23 |
| Support Level | $4.10 | $1.43 |
| Resistance Level | $9.22 | $1.80 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 51.62 | 30.49 |
Price Performance
Historical ComparisonAbout KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.